ADA Scientific Sessions 2025 Abstract
Development of a Novel One-Month Long-Acting Injectable Semaglutide (IVL3021) and Tirzepatide (IVL3024) with Well-Controlled Pharmacokinetic Profiles and Enhanced Quality of Life Window
By Ju Hee Kim
Experiments in animalsInterventions
The paper
Seongnam
ADA Scientific Sessions 2025 Abstract, 13 Jun 2025
Presented at ADA Scientific Sessions 2025, poster 754-P
